Clinical Trial Update: Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ruxolitinib before, during, and after hematopoietic cell transplant in older patients with myelofibrosis and myelodysplastic/m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Myeloproliferative Neoplasms
• Myelofibrosis

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Myelodysplastic/Myeloproliferative Neoplasm, Primary Myelofibrosis | Phase 2 | Status: RECRUITING